Step 1 cardiac drugs Flashcards

1
Q

hydralazine mechanism

A

increases cGMP–smooth muscle relaxation; arterial dilator, reduces afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

hydralazine use

A

severe hypertension, CHF; first line for HTN in pregnancy with methyldopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

hydralazine coadministered with what? Why?

A

beta blocker; to prevent reflex tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hydralazine toxicity

A

headaches, nausea, fluid retention, reflex tachycardia, angina, LUPUS LIKE SYNDROME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ca channel blockers

A

nifedipine, verapamil, diltiazem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ca channel blocker mechanism

A

block voltage dependent L-type Ca channels of cardiac and smooth muscle–reduce contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

affinity of Ca channel blockers

A

heart: verapamil > diltiazem > nifedipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ca channel blocker use

A

hypertension, angina, arrhythmias, Prinzmetal’s angina, Raynaud’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ca channel blocker toxicity

A

cardiac depression, AV block, peripheral edema, flushing, dizziness, constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

nitroglycerin, isosorbide dinitrate mechanism

A

release of NO in smooth muscle causes increase in cGMP and smooth muscle relaxation; dilates veins more than arteries; decreases preload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

nitroglycerin, isosorbide dinitrate use

A

angina, pulmonary edema; aphrodesiac and erection enhancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

nitroglycerin, isosorbide dinitrate toxicity

A

reflex tachycardia, hypotension, flushing, headache, “Monday disease”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

drugs for malignant hypertension

A

nitroprusside, fenaldopam, diazoxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

nitroprusside mechanism

A

increase cGMP via direct release of NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

nitroprusside toxicity

A

releases cyanide (so can cause toxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

fenaldopam mechanism

A

dopamine D1 receptor agonist–relaxes renal vascular smooth muscle, splanchnic, peripheral and coronary vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

diazoxide mechanism

A

opens K channels–hyperpolarizes cell and relax vascular smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

diazoxide toxicity

A

hyperglycemia (because it reduces insulin release)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

class II antiarrhythmic drugs

A

beta blockers–timolol, propanolol, metoprolol, atenolol, esmolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

class II antiarrhythmic mechanism

A

decrease sympathetic tone, slow AV nodal conduction (decreases cAMP and Ca); decrease slope of Phase 4–increase PR interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

class II anti-arrhythmic use

A

V-tach, slowing ventricular rate during atrial fib and flutter (remember they only act on the ventricle!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

class II antiarrhythmic toxicity

A

impotence, exacerbation of asthma, bradycardia, AV block, sedation, sleep disturbances, mask hypoglycemia, metoprolol can cause dylipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

class 1a antiarrhythmics

A

procainamide, quinidine, disopyramide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

class 1a antiarrhythmic mechanism

A

Na channel blockers, Phase 0 and 3–slow both; intermediate channel blockers; prolong QT and increase refractory period increase AP duration; also have some action at K channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
class 1a antiarrhythmic toxicity
arrhythmias (from long QT), procainamide can cause SLE like syndrome, quinidine--cinochism---tinnitus and headache), thrombocytopenia
26
class 1a antiarrhythmic uses
atrial and ventricular arrhythmias (esp reentrant and ectopic and supraventricular tachycardia)
27
class 1c antiarrhythmics
flecainide, encainide, propafenone
28
class 1c antiarrhythmic mechanism
Na channel blockers, slow Phase 0 (no, effect on Phase 3), high Na channel avidity so slow off time, no effect on AP duration
29
class 1c antiarrhythmic use
last resort in refractory arrhythmias; V-tach that progresses to V-fib; intractable SVT
30
class 1c toxicity
contraindicated in MI (proarrhythmic); significantly prolongs refractory period in AV node
31
class 1b antiarrhythmics
lidocaine, mexiletine, tocainide
32
class 1b antiarrhythmic mechanism
Na channel blockers; poor avidity--quick on and off; slow Phase 0 but increase Phase 3 slope; decrease AP duration; preferentially rapidly depolarizing or ischemic cells; best for post-MI patients
33
class 1b antiarrhythmic toxicity
local anesthetic, CNS stimulation/depression, cardiovascular depression
34
class III antiarrhythmics
ibutilide, amiodarone (has I-IV actions), betyrium, sotolol, dofetilide
35
class III antiarrhythmic mechanism
block K channels, hyperpolarize to prolong refractory period and AP duration, increase QT interval
36
class III antiarrhythmic use
used when others fail--supraventricular and ventricular tachyarrhythmias
37
class 1b antiarrhythmic use
acute ventricular arrhythmias or digitalis-induced arrhythmias
38
class III antiarrhythmic toxicity
risk of new arrhythmia (because of long QT)
39
sotolol toxicity
torsades de pointes; excessive beta block
40
bretylium toxicity
new arrhythmias, hypotension
41
ibulitide toxicity
torsades de pointes
42
amiodarone toxicity
pulmonary fibrosis, hepatotoxicity, hypo/hyperthyroidism, corneal deposits, blue gray skin deposits and photodermatitis, neurologic effects, constipation, bradycardia, heart block, CHF, P450 inhibitor
43
class IV antiarrhythmics
verapamil, diltiazem
44
class IV antiarrhythmic mechanism
Ca channel blocker, decreases conduction velocity, increases refractory period and PR interval
45
class IV antiarrhythmic use
nodal arrhythmias
46
class IV antiarrhythmic toxicity
constipation, flushing, edema, CHF, AV block, sinus node depression; verapamil: gingival hyperplasia
47
adenosine mechanism
increases flow of K from AV nodal cells to hyperpolarize the cell and decrease Ca current; very short acting (selective coronary dilator)
48
adenosine use
diagnosing and abolishing supraventricular tachycardia
49
adenosine toxicity
coronary steal phenomenon, flushing, hypotension, chest pain, effects blocked by theophylline
50
K+ use in arrhythmias
depresses ectopic pacemaker cells in hypokalemia (ie digoxin toxicity)
51
Mg 2+ use in arrhythmias
tosades de pointes and digoxin toxicity
52
dipyramidole mechanism
inhibits breakdown of adenosine (selective coronary vasodilator)
53
dipyramidole toxicity
coronary steal phenomenon
54
statin mechanism
HMG-CoA reductase inhibitors (inhibit melavonate conversion)
55
effects of statins
primarily lower LDL, small decrease in HDL and TG
56
statin toxicity
rhabdomyolysis and hepatotoxicity
57
niacin mechanism
inhibits lipolysis in adipose tissue; reduces hepatic VLDL secretion into circulation
58
effects of niacin
moderate decrease in LDL, increase in HDL, small decrease in TG (acts primarily on HDL)
59
niacin toxicity
flushing (take aspirin 30 minutes before), hyperglycemia (acanthosis nigricans), hyperuricemia
60
cholestyramine mechanism
prevents intestinal reabsorption of bile acids; liver must use cholesterol to make more (bile acid resin)
61
colestipol mechanism
prevents intestinal reabsorption of bile acids; liver must use cholesterol to make more (bile acid resin)
62
colesevelam
prevents intestinal reabsorption of bile acids; liver must use cholesterol to make more (bile acid resin)
63
effects of bile acid resins
moderate decrease in LDL, slight increase in HDL and triglycerides
64
bile acid resin toxicity
patients hate it (GI discomfort and bad taste), decreased absorption of fat soluble vitamins, cholesterol gallstones
65
ezetimibe
cholesterol absorption blocker (at small intestine brush border)
66
effects of ezetimibe
only effect is lowering LDL (no HDL, TG effects)
67
ezetimibe toxicity
rare increase in LFTs
68
gemfibrizol mechanism
upregulate lipoprotein lipase (LPL) to increase TG clearance
69
clofibrate mechanism
upregulate lipoprotein lipase (LPL) to increase TG clearance
70
bezafibrate mechanism
upregulate lipoprotein lipase (LPL) to increase TG clearance
71
fenofibrate mechanism
upregulate lipoprotein lipase (LPL) to increase TG clearance
72
effects of fibrates
biggest effect is decrease in TG, small decrease in LDL and small increase in HDL
73
fibrate toxicity
myositis, hepatotoxicity, cholesterol gallstones
74
digoxin mechanism
direct inhibition of Na/K ATPase leads to indirect inhibition of Na/Ca exchanger (increase in intracellular Ca and positive inotropy); stimulates vagus nerve
75
digoxin use
CHF, atrial fibrillation
76
digoxin toxicity
cholinergic: nausea, vomiting, diarrhea, blurry yellow vision, decreased appetite; increased PR, short QT, scooping, T wave inversion, arrhythmia, hyperkalemia; worse with renal failure, hypokalemia, quinidine
77
digoxin antidote
slowly normalize K, lidocaine, Digiband (anti-digoxin fragments), Mg